Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

XenoSure Biologic Patch

K-Number: K190882 · 2020-02-13

Decision Date2020-02-13
Product CodePSQ
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

XenoSure Biologic Patch is a medical device manufactured by Lemaitre Vascular. It received FDA 510(k) clearance on 2020-02-13 under approval number K190882. The device is classified under product code PSQ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the XenoSure Biologic Patch?

XenoSure Biologic Patch is a medical device that received FDA 510(k) clearance on 2020-02-13. It is manufactured by Lemaitre Vascular. The 510(k) number is K190882.

When was XenoSure Biologic Patch approved by the FDA?

XenoSure Biologic Patch received FDA 510(k) clearance on 2020-02-13, under approval number K190882.

What company makes XenoSure Biologic Patch?

XenoSure Biologic Patch is manufactured by Lemaitre Vascular.

What is the FDA product code for XenoSure Biologic Patch?

The FDA product code for XenoSure Biologic Patch is PSQ.

Other Devices by Lemaitre Vascular

Related Devices (Code: PSQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.